日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies.

CD47阻断驱动的坏死性凋亡可与BCL-2抑制驱动的淋巴恶性肿瘤细胞凋亡相辅相成。

Chong Stephen J F, Valentin Rebecca, Wang Jing, Zhu Fen, Gokhale Prafulla C, Eschle Benjamin K, Garbicz Filip, Iskandar Kartini, Sewastianik Tomasz, Toh Brienne C Y, Penailillo Johany, Peluso Marisa O, Zhang Jeremy, Hackett Liam, Collins Mary C, Lehmberg Timothy Z, Adam Ammar, Zhang Li, Armet Caroline M, Rausch Matthew, Lee Benjamin H, Holland Pamela M, Palombella Vito J, Paterson Alison M, Kong Li Ren, Ten Hacken Elisa, Guerriero Jennifer L, Herbaux Charles, Wu Catherine J, Chng Wee Joo, Pervaiz Shazib, Niemann Carsten U, Carrasco Ruben D, Davids Matthew S

Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3

Brexucabtagene autoleucel 用于 BTKi 初治复发/难治性套细胞淋巴瘤:ZUMA-2 队列 3 的主要分析

van Meerten, Tom; Kersten, Marie José; Iacoboni, Gloria; Hess, Georg; Mutsaers, Pim; García-Sancho, Alejandro Martín; Goy, Andre; Giné, Eva; Hill, Brian T; Weng, Wen-Kai; Reagan, Patrick M; Patel, Krish; Galal, Ahmed; Herbaux, Charles; Sanderson, Robin; Forcade, Edouard; Topp, Max S; Houot, Roch; Zheng, Dan; Zhang, Wangshu; Kanska, Justyna; Shen, Rhine R; Damico Khalid, Rita; Kloos, Ioana; Dreyling, Martin; Wang, Michael L

Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression

单细胞基因组学揭示了MYC相关的代谢激活和T前淋巴细胞白血病进展中的细胞相互作用改变

Wahnschaffe, Linus; Jungherz, Dennis; Müller, Tony A; Pemovska, Tea; Pichler, Alexander; Poulain, Stéphanie; Julia, Edith; Timonen, Sanna; Böttcher, Martin; Jiang, Qu; Beverungen, David; Bischoff, Julia; Franitza, Marek; Georgomanolis, Theodoros; Becker, Kerstin; Hallek, Michael; Mougiakakos, Dimitrios; Zenz, Thorsten; Mustjoki, Satu; Bachy, Emmanuel; Herbaux, Charles; Schrader, Alexandra; Pflug, Natali; Staber, Philipp B; Braun, Till; Herling, Marco

Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group

LYSA集团开展的DESCAR-T研究:套细胞淋巴瘤患者抗CD19 CAR T细胞疗法失败后的预后

Aymard, Marion; Cheminant, Morgane; Houot, Roch; Cuozzo, Anne; Gat, Elodie; Thieblemont, Catherine; Ricard, Laure; Roulin, Louise; Bouabdallah, Krimo; Safar, Violaine; Guidez, Stéphanie; Fayard, Amandine; Brisou, Gabriel; Ysebaert, Loic; Hermine, Olivier; Tessoulin, Benoît; Herbaux, Charles; Le Gouill, Steven; Sarkozy, Clémentine

Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma

POLARIX 研究五年结果:比较 Pola-R-CHP 和 R-CHOP 方案治疗弥漫性大 B 细胞淋巴瘤患者的疗效

Morschhauser, Franck; Salles, Gilles; Sehn, Laurie H; Herrera, Alex F; Friedberg, Jonathan W; Trněný, Marek; Lenz, Georg; Sharman, Jeff P; Herbaux, Charles; Burke, John M; Matasar, Matthew; Collins, Graham P; Mehta-Shah, Neha; Oberic, Lucie; Chauchet, Adrien; Jurczak, Wojciech; Song, Yuqin; Pinto, Antonio; Rai, Shinya; Izutsu, Koji; Greil, Richard; Mykhalska, Larysa; Bergua-Burgués, Juan M; Cheung, Matthew C; Shin, Ho-Jin; Hapgood, Greg; Munhoz, Eduardo; Abrisqueta, Pau; Gau, Jyh-Pyng; Jiang, Yanwen; McCall, Bruce; Chohan, Saibah; Sugidono, Matthew; Yan, Mark; Batlevi, Connie Lee; Tilly, Hervé; Flowers, Christopher R

BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia

BCL-2依赖性是慢性淋巴细胞白血病治疗反应的有利预测指标。

Chong, Stephen Jun Fei; Lu, Junyan; Valentin, Rebecca; Lehmberg, Timothy Z; Eu, Jie Qing; Wang, Jing; Zhu, Fen; Kong, Li Ren; Fernandes, Stacey M; Zhang, Jeremy; Herbaux, Charles; Goh, Boon Cher; Brown, Jennifer R; Niemann, Carsten U; Huber, Wolfgang; Zenz, Thorsten; Davids, Matthew S

Development of a robust BH3 drug toolkit for precision medicine in hematologic malignancies

开发用于血液系统恶性肿瘤精准治疗的稳健型BH3药物工具包

Valentin Jacquier ,Andréa Romero ,Caroline Molinaro ,Ritu Somayaji ,Matthieu Abouladze ,Ouissem Karmous Gadacha ,Sara Ovejero ,Hugues de Boussac ,Ludovic Gabellier ,Matthew S Davids ,Jérôme Moreaux ,Charles Herbaux

Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

tazemetostat联合R-CHOP方案治疗新诊断为弥漫性大B细胞淋巴瘤的老年患者的疗效:LYSA研究的EpiRCHOP II期研究结果

Sarkozy, Clémentine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cédric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stéphanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent

Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: real-world data from the EarlyMIND study

tafasitamab联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤的临床获益:来自EarlyMIND研究的真实世界数据

Brisou, Gabriel; Paillassa, Jérôme; Bernard, Sophie; Tournilhac, Olivier; Fornecker, Luc-Matthieu; Maloisel, Frédéric; Gastaud, Lauris; Durot, Eric; Tempescul, Adrian; Braun, Thorsten; Ivanov, Vadim; Cherel, Brieuc; Serrier, Caroline; Delage, Jeremy; El Yamani, Abderrazak; Delapierre, Baptiste; Lebras, Laure; Lestang, Elsa; Villesuzanne, Camille; Agape, Philippe; Escure, Guillaume; Fouillet, Ludovic; Nicol, Christophe; Olivier, Gaëlle; Levy, Anthony; Le Bris, Anne-Sophie; Cassuto, Ophélie; Jacquemelle, Laura; Haioun, Corinne; Herbaux, Charles

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

CAR-T 细胞疗法治疗后高级别 B 细胞淋巴瘤与其他大 B 细胞淋巴瘤的疗效比较:一项 DESCAR-T LYSA 研究

Phina-Ziebin, Xavier; Bachy, Emmanuel; Gros, François-Xavier; Di Blasi, Roberta; Herbaux, Charles; Bay, Jacques Olivier; Carras, Sylvain; Bories, Pierre; Casasnovas, Olivier; Jardin, Fabrice; Morschhauser, Franck; Guffroy, Blandine; Mohty, Mohamad; Gat, Elodie; Calvani, Julien; Parrens, Marie-Cécile; Poullot, Elsa; Traverse-Glehen, Alexandra; Roulin, Louise